New cell-probing technology for early breast cancer surgery
Part of Cancer, Skin clinical trials.
This trial tests a new technology that helps doctors examine cells during surgery for early-stage breast cancer. It may help make the sentinel lymph node biopsy more accurate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are female.
- You have been diagnosed with invasive breast cancer or ductal carcinoma in situ (an early form of breast cancer).
- Your doctor plans to do a sentinel lymph node biopsy (a procedure to check if cancer has spread to the first lymph nodes).
- You are willing to take part in the study and sign a consent form.
- You do not have an allergy to methylene blue or sodium citrate (dyes used in the procedure).
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special probe that lights up cancer cells to quickly check if breast cancer has spread to nearby lymph nodes. It may help doctors decide how much surgery is needed.
This trial tests a new imaging method to help doctors see if any cancer cells are left at the edges of removed tissue during breast cancer surgery. It may reduce the need for follow-up surgeries.
This trial tests whether a less invasive way to check if cancer has spread to lymph nodes (sentinel node biopsy) works as well as the standard method. It is for people with early-stage endometrial cancer having surgery.
This study tests a special dye that helps surgeons see breast cancer tissue and nearby lymph nodes more clearly during surgery. The goal is to make sure all cancer is removed while sparing healthy tissue.
This trial studies whether very small deposits of cancer (called micrometastasis or isolated tumor cells) are found in sentinel lymph nodes in early endometrial or cervical cancer. The goal is to better understand what these findings may mean for cancer spread and treatment planning.
This trial tests a scanner that checks removed breast tissue during surgery to help surgeons remove all cancer the first time. If it works, fewer women may need a second operation.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.